🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

6+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 6 of 6 recruiting trials for “malignant-germ-cell-tumor-of-the-corpus-uteri”

Phase 1RecruitingNCT07029399 ↗

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

🏥 NiKang Therapeutics, Inc.📍 14 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT05619913 ↗

EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma

👨‍⚕️ Clare Scott, AM MB BS PhD, Peter MacCallum Cancer Centre, Australia📍 6 sites📅 Started May 2023View details ↗
Phase 2RecruitingNCT04804007 ↗

Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT

👨‍⚕️ Nabil Adra, MD, Indiana University📍 1 site📅 Started Mar 2021View details ↗
Phase 1RecruitingNCT04038619 ↗

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

👨‍⚕️ Yinghong Wang, M.D. Anderson Cancer Center📍 1 site📅 Started Feb 2021View details ↗
Phase 1, PHASE2RecruitingNCT03686124 ↗

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

👨‍⚕️ Cedrik Britten, M.D., Immatics US, Inc.📍 19 sites📅 Started May 2019View details ↗
Phase 1, PHASE2RecruitingNCT02830724 ↗

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

👨‍⚕️ James C Yang, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2017View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →